Table 2.
Lists the meta-scoring tier list and other relevant parameters used during treatment planning.
| Tier 0 (τ0) | Tier 1 (τ1) | Tier 2 (τ2) | Tier 3 (τ3) | Overlap Priority | Reference Dose () | ||
|---|---|---|---|---|---|---|---|
| Prostate Cases | HI | CI | Sparing (Rectum, Bladder) | Sparing (FH R, FH L, Body) | PTV | 1 | 74 |
| Rectum | 2 | 0 | |||||
| Bladder | 2 | 0 | |||||
| FH R | 2 | 30 | |||||
| FH L | 2 | 30 | |||||
| Body | 2 | 30 | |||||
| Head and Neck Cases | HI (PTV 70, PTV 56, PTV 52) | CI (PTV 70) | Sparing (Spinal Cord, Brainstem, Parotid R, Parotid L, Oral Cavity, Larynx,) | Sparing (Body) | PTV 70 | 1 | 72 |
| PTV 56 | 2 | 58 | |||||
| PTV 52 | 3 | 54 | |||||
| Cord | 4 | 30 | |||||
| Brainstem | 4 | 30 | |||||
| Parotid R | 4 | 0 | |||||
| Parotid L | 4 | 0 | |||||
| Oral Cavity | 4 | 0 | |||||
| Larynx | 4 | 0 | |||||
| Body | 4 | 30 |